Galectin-3 Interactions with Glycosphingolipids

Cummings, 2009, Galectins Leffler, 2004, Introduction to galectins, Glycoconjugate J, 19, 433, 10.1023/B:GLYC.0000014072.34840.04 Barondes, 1994, Galectins. Structure and function of a large family of animal lectins, J Biol Chem, 269, 20807, 10.1016/S0021-9258(17)31891-4 Herrmann, 1993, Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase, J Biol Chem, 268, 26704, 10.1016/S0021-9258(19)74370-1 Grigorian, 2009, T-cell growth, cell surface organization, and the galectin-glycoprotein lattice, Immunol Rev, 230, 232, 10.1111/j.1600-065X.2009.00796.x Hsu, 2004, Regulation of cellular homeostasis by galectins, Glycoconjugate J, 19, 507, 10.1023/B:GLYC.0000014080.95829.52 Liu, 2002, Intracellular functions of galectins, Biochim Biophys Acta, 1572, 263, 10.1016/S0304-4165(02)00313-6 Vasta, 2009, Roles of galectins in infection, Nat Rev Microbiol, 7, 424, 10.1038/nrmicro2146 Yang, 2003, Galectins in cell growth and apoptosis, Cell Mol Life Sci, 60, 267, 10.1007/s000180300022 Liu, 2005, Galectins as modulators of tumour progression, Nat Rev Cancer, 5, 29, 10.1038/nrc1527 Liu, 2000, Galectins: a new family of regulators of inflammation, Clin Immunol, 97, 79, 10.1006/clim.2000.4912 Wennekes, 2009, Glycosphingolipids—nature, function, and pharmacological modulation, Angew Chem Int Ed Engl, 48, 8848, 10.1002/anie.200902620 Schnaar, 2009, Glycosphingolipids Hakomori, 1997, Glycosphingolipid antigens and cancer therapy, Chem Biol, 4, 97, 10.1016/S1074-5521(97)90253-2 Sorice, 1999, Glycosphingolipid domains on cell plasma membrane, Biosci Rep, 19, 197, 10.1023/A:1020277820120 Boscher, 2012, Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell–cell junctions of mammary carcinoma cells, J Biol Chem, 287, 32940, 10.1074/jbc.M112.353334 Kopitz, 2001, Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3, J Biol Chem, 276, 35917, 10.1074/jbc.M105135200 Iwabuchi, 1998, GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells, J Biol Chem, 273, 9130, 10.1074/jbc.273.15.9130 Ideo, 2003, The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity, Glycobiology, 13, 713, 10.1093/glycob/cwg094 Togayachi, 2010, Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation, Proc Natl Acad Sci U S A, 107, 11900, 10.1073/pnas.0914298107 Hattori, 1992, Glycolipid of human pancreatic cancer; the appearance of neolacto-series (type 2 chain) glycolipid and the presence of incompatible blood group antigen in tumor tissues, Biochim Biophys Acta, 1125, 21, 10.1016/0005-2760(92)90150-T Nesmelova, 2008, Understanding galectin structure–function relationships to design effective antagonists, 33 Hirabayashi, 2002, Oligosaccharide specificity of galectins: a search by frontal affinity chromatography, Biochim Biophys Acta, 1572, 232, 10.1016/S0304-4165(02)00311-2 Knibbs, 1993, Carbohydrate-binding protein 35. II. Analysis of the interaction of the recombinant polypeptide with saccharides, J Biol Chem, 268, 14940, 10.1016/S0021-9258(18)82423-1 Nagae, 2009, Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain, Glycobiology, 19, 112, 10.1093/glycob/cwn121 Zhou, 2003, Why are glycoproteins modified by poly-N-acetyllactosamine glyco-conjugates?, Curr Protein Pept Sci, 4, 1, 10.2174/1389203033380304 Stanley, 2009, Structures common to different glycans Srinivasan, 2009, Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3, Glycoconjugate J, 26, 445, 10.1007/s10719-008-9194-9 Tsuboi, 2011, A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans, EMBO J, 30, 3173, 10.1038/emboj.2011.215 Tsuboi, 2012, Two opposing roles of O-glycans in tumor metastasis, Trends Mol Med, 18, 224, 10.1016/j.molmed.2012.02.001 Salomonsson, 2010, Mutational tuning of galectin-3 specificity and biological function, J Biol Chem, 285, 35079, 10.1074/jbc.M109.098160 Seetharaman, 1998, X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-Å resolution, J Biol Chem, 273, 13047, 10.1074/jbc.273.21.13047 Barlow, 1983, Ion-pairs in proteins, J Mol Biol, 168, 867, 10.1016/S0022-2836(83)80079-5 Kumar, 2002, Close-range electrostatic interactions in proteins, ChemBioChem, 3, 604, 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X Yoshida, 2010, X-ray structures of human galectin-9C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose, J Biol Chem, 285, 36969, 10.1074/jbc.M110.163402 Bian, 2011, Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen, PLoS One, 6, e25007, 10.1371/journal.pone.0025007 Leffler, 1986, Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides, J Biol Chem, 261, 10119, 10.1016/S0021-9258(18)67499-X Stowell, 2008, Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens, J Biol Chem, 283, 10109, 10.1074/jbc.M709545200 Sasaki, 1997, Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis, Proc Natl Acad Sci U S A, 94, 14294, 10.1073/pnas.94.26.14294 Cindolo, 1999, Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas, Int J Cancer, 84, 39, 10.1002/(SICI)1097-0215(19990219)84:1<39::AID-IJC8>3.0.CO;2-E Sakaki, 2008, Serum level of galectin-3 in human bladder cancer, J Med Invest, 55, 127, 10.2152/jmi.55.127 Collins, 2007, Slow diffusion of lactose out of galectin-3 crystals monitored by X-ray crystallography: possible implications for ligand-exchange protocols, Acta Crystallogr Sect D Biol Crystallogr, 63, 415, 10.1107/S090744490605270X Evans, 2006, Scaling and assessment of data quality, Acta Crystallogr Sect D Biol Crystallogr, 62, 72, 10.1107/S0907444905036693 McPhillips, 2002, Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines, J Synchrotron Radiat, 9, 401, 10.1107/S0909049502015170 Battye, 2011, iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM, Acta Crystallogr Sect D Biol Crystallogr, 67, 271, 10.1107/S0907444910048675 Navaza, 1994, AMoRe: an automated package for molecular replacement, Acta Crystallogr Sect A Found Crystallogr, 50, 157, 10.1107/S0108767393007597 Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr Sect D Biol Crystallogr, 67, 355, 10.1107/S0907444911001314 Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr Sect D Biol Crystallogr, 67, 235, 10.1107/S0907444910045749 Emsley, 2010, Features and development of Coot, Acta Crystallogr Sect D Biol Crystallogr, 66, 486, 10.1107/S0907444910007493 Davis, 2007, MolProbity: all-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Res, 35, W375, 10.1093/nar/gkm216 Vaguine, 1999, SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model, Acta Crystallogr Sect D Biol Crystallogr, 55, 191, 10.1107/S0907444998006684 McNicholas, 2011, Presenting your structures: the CCP4mg molecular-graphics software, Acta Crystallogr Sect D Biol Crystallogr, 67, 386, 10.1107/S0907444911007281 Bum-erdene, 2013, Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3 specific inhibitors, ChemBioChem, 14, 1331, 10.1002/cbic.201300245 Hess, 2008, GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation, J Chem Theory Comput, 4, 435, 10.1021/ct700301q Lindorff-Larsen, 2010, Improved side-chain torsion potentials for the Amber ff99SB protein force field, Proteins, 78, 1950, 10.1002/prot.22711 Essmann, 1995, A smooth particle mesh Ewald method, J Chem Phys, 103, 8577, 10.1063/1.470117 Hess, 2008, P-LINCS: a parallel linear constraint solver for molecular simulation, J Chem Theory Comput, 4, 116, 10.1021/ct700200b Hess, 1998, LINCS: a linear constraint solver for molecular simulations, J Comput Chem, 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H Wang, 2004, Development and testing of a general amber force field, J Comput Chem, 25, 1157, 10.1002/jcc.20035 Sousa da Silva, 2012, ACPYPE—AnteChamber PYthon Parser interfacE, BMC Res Notes, 5, 367, 10.1186/1756-0500-5-367 Wang, 2006, Automatic atom type and bond type perception in molecular mechanical calculations, J Mol Graphics Modell, 25, 247, 10.1016/j.jmgm.2005.12.005 Jakalian, 2002, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J Comput Chem, 23, 1623, 10.1002/jcc.10128 Bussi, 2007, Canonical sampling through velocity-rescaling, J Chem Phys, 126, 014101, 10.1063/1.2408420 Parrinello, 1981, Polymorphic transitions in single crystals: a new molecular dynamics method, J Appl Phys, 52, 7182, 10.1063/1.328693 Nose, 1983, Constant pressure molecular dynamics for molecular systems, Mol Phys, 50, 1055, 10.1080/00268978300102851